tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ZYNE is currently covered by 2 analysts with an average price target of $7.34. This is a potential upside of $6.04 (464.62%) from yesterday's end of day stock price of $1.3.
Zynerba Pharmaceuticals's activity chart (see below) currently has 56 price targets and 49 ratings on display. The stock rating distribution of ZYNE is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 15.42% with an average time for these price targets to be met of 104 days.
Highest price target for ZYNE is $1.11, Lowest price target is $1.11, average price target is $7.34.
Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.
Currently out of the existing stock ratings of ZYNE, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1.11
$-0.19 (-14.62%)
8 months 2 days ago
0/7 (0%)
$-0.18 (-13.95%)
Hold
16
8 months 3 days ago
1/4 (25%)
$3.93 (32.56%)
103
Buy
8
$6.7 (515.38%)
8
2 years 11 months 12 days ago
2/8 (25%)
$3.99 (99.50%)
113
Buy
7.25
$5.95 (457.69%)
11
3 years 1 months 8 days ago
0/4 (0%)
$2.91 (67.05%)
Buy
9
$7.7 (592.31%)
12
3 years 3 months 28 days ago
0/5 (0%)
$5.56 (161.63%)
What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?
